Development of a cancer-targeted tissue-specific promoter system.

Development of a cancer-targeted tissue-specific promoter system.

Item
http://www.wikidata.org/entity/Q40598244
PARP-2 interacts with TTF-1 and regulates expression of surfactant protein-B.Viral-based gene delivery and regulated gene expression for targeted cancer therapy.Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy.Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer.Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.Inhibitory effect of human telomerase antisense oligodeoxyribonucleotides on the growth of gastric cancer cell lines in variant tumor pathological subtype.Perturbation of interaction networks for application to cancer therapy.Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration.Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma.
P2860

Development of a cancer-targeted tissue-specific promoter system.

Item
http://www.wikidata.org/entity/Q40598244
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Development of a cancer-targeted tissue-specific promoter system.
@en
type
label
Development of a cancer-targeted tissue-specific promoter system.
@en
prefLabel
Development of a cancer-targeted tissue-specific promoter system.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Development of a cancer-targeted tissue-specific promoter system.
@en
P2093
P304
P31
P356
10.1158/0008-5472.CAN-03-2507
P407
P433
P478
P577
P698